Clinical Trial Update: PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 trial evaluating PGL4001 for reducing symptoms of uterine fibroids (uterine leiomyomata).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• PGL4001

Snippet

Sponsor: PregLem SA | Conditions: Uterine Fibroids | Phase 3 | Status: COMPLETED